Penserra Capital Management LLC Eli Lilly & CO Transaction History

Penserra Capital Management LLC

$4.61 Billion
Q3 2024

A detailed history of Penserra Capital Management LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Penserra Capital Management LLC holds 870 shares of LLY stock, worth $677,730. This represents 0.02% of its overall portfolio holdings.

Number of Shares

870

Previous 599 45.24%

Holding current value

$677,730

Previous $543,000 41.8%

% of portfolio

0.02%

Previous 0.01%

26 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	BUY	$772.14 - $960.02 $209,249 - $260,165	271 Added 45.24%	870 $770,000
Q2 2024 Aug 13, 2024	BUY	$724.87 - $909.04 $377,657 - $473,609	521 Added 667.95%	599 $543,000
Q1 2024 May 15, 2024	SELL	$592.2 - $792.28 $2.15 Million - $2.87 Million	-3,624 Reduced 97.89%	78 $60,000
Q4 2023 Feb 14, 2024	SELL	$525.19 - $619.13 $1.24 Million - $1.46 Million	-2,354 Reduced 38.87%	3,702 $2.16 Million
Q3 2023 Nov 15, 2023	BUY	$434.7 - $599.3 $408,618 - $563,342	940 Added 18.37%	6,056 $3.25 Million
Q2 2023 Aug 11, 2023	BUY	$350.74 - $468.98 $1.78 Million - $2.37 Million	5,064 Added 9738.46%	5,116 $2.4 Million
Q4 2022 Feb 13, 2023	BUY	$321.55 - $374.67 $16,720 - $19,482	52 New	52 $19,000
Q2 2022 Aug 15, 2022	BUY	$278.73 - $327.27 $3.33 Million - $3.91 Million	11,945 Added 9954.17%	12,065 $3.91 Million
Q1 2022 May 13, 2022	SELL	$234.69 - $291.66 $8,448 - $10,499	-36 Reduced 23.08%	120 $34,000
Q3 2021 Nov 15, 2021	BUY	$221.6 - $272.71 $2,437 - $2,999	11 Added 7.59%	156 $36,000
Q2 2021 Aug 12, 2021	BUY	$180.55 - $233.54 $26,179 - $33,863	145 New	145 $33,000
Q4 2020 Feb 12, 2021	SELL	$130.46 - $172.63 $70,448 - $93,220	-540 Closed	0 $0
Q3 2020 Nov 13, 2020	SELL	$146.22 - $169.13 $4,679 - $5,412	-32 Reduced 5.59%	540 $79,000
Q2 2020 Aug 14, 2020	SELL	$136.42 - $164.18 $14,051 - $16,910	-103 Reduced 15.26%	572 $93,000
Q1 2020 May 14, 2020	SELL	$119.05 - $147.35 $16,309 - $20,186	-137 Reduced 16.87%	675 $103,000
Q4 2019 Feb 14, 2020	BUY	$106.92 - $132.43 $12,723 - $15,759	119 Added 17.17%	812 $114,000
Q3 2019 Nov 15, 2019	BUY	$106.79 - $116.16 $29,153 - $31,711	273 Added 65.0%	693 $77,000
Q2 2019 Aug 13, 2019	SELL	$110.79 - $129.32 $64,036 - $74,746	-578 Reduced 57.92%	420 $46,000
Q1 2019 May 08, 2019	SELL	$111.31 - $131.02 $1.14 Million - $1.34 Million	-10,241 Reduced 91.12%	998 $129,000
Q4 2018 Feb 06, 2019	SELL	$105.9 - $118.64 $787,260 - $881,969	-7,434 Reduced 39.81%	11,239 $1.3 Million
Q3 2018 Nov 05, 2018	BUY	$85.86 - $107.31 $1.26 Million - $1.58 Million	14,723 Added 372.73%	18,673 $2 Million
Q2 2018 Aug 13, 2018	BUY	$75.7 - $86.88 $45,874 - $52,649	606 Added 18.12%	3,950 $337,000
Q1 2018 May 08, 2018	BUY	$74.21 - $87.6 $19,591 - $23,126	264 Added 8.57%	3,344 $258,000
Q4 2017 Feb 07, 2018	BUY	$81.94 - $87.89 $39,658 - $42,538	484 Added 18.64%	3,080 $260,000
Q3 2017 Oct 26, 2017	BUY	$77.07 - $85.54 $23,737 - $26,346	308 Added 13.46%	2,596 $224,000
Q2 2017 Aug 21, 2017	BUY	N/A	2,288	2,288 $188,000

Others Institutions Holding LLY

# of Institutions

4,011

Shares Held

752M

Call Options Held

8.27M

Put Options Held

10.5M

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $740B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Penserra Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Penserra Capital Management LLC with notifications on news.

Account

Penserra Capital Management LLC Eli Lilly & CO Transaction History